Selected research
Industry Research
Chronic Venous Insufficiency Industry Research Report 2026
Market perspective
The global Chronic Venous Insufficiency market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Chronic Venous Insufficiency market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Chronic Venous Insufficiency market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Chronic Venous Insufficiency market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Chronic Venous Insufficiency include Suzhou Yinluo Medical Devices, Suzhou Tianhong Shengjie Medical Devices, Shanghai Lanmai Medical Technology, Shanghai Ensheng Medical Technology, Hangzhou Weiqiang Medical Technology, Zylox-Tonbridge Medical Technology, Teva, Sun Pharma and Philips, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Chronic Venous Insufficiency market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Chronic Venous Insufficiency.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chronic Venous Insufficiency Market by Company
Suzhou Yinluo Medical Devices
Suzhou Tianhong Shengjie Medical Devices
Shanghai Lanmai Medical Technology
Shanghai Ensheng Medical Technology
Hangzhou Weiqiang Medical Technology
Zylox-Tonbridge Medical Technology
Teva
Sun Pharma
Philips
Pfizer
optimed Medizinische Instrumente
Mylan
Medtronic
Cook Ireland
Boston Scientific
BD(Angiomed)
Allergan
AbbVie
Abbott
3M
Chronic Venous Insufficiency Segment by Type
Medical Equipment and Consumables
Drugs
Chronic Venous Insufficiency Segment by Application
Hospital
Clinic
Other
Chronic Venous Insufficiency Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Venous Insufficiency market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chronic Venous Insufficiency and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Venous Insufficiency.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Chronic Venous Insufficiency companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical Equipment and Consumables
- Drugs
Applications
- Hospital
- Clinic
- Other
Companies covered
- Suzhou Yinluo Medical Devices
- Suzhou Tianhong Shengjie Medical Devices
- Shanghai Lanmai Medical Technology
- Shanghai Ensheng Medical Technology
- Hangzhou Weiqiang Medical Technology
- Zylox-Tonbridge Medical Technology
- Teva
- Sun Pharma
- Philips
- Pfizer
- optimed Medizinische Instrumente
- Mylan
- Medtronic
- Cook Ireland
- Boston Scientific
- BD(Angiomed)
- Allergan
- AbbVie
- Abbott
- 3M
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Chronic Venous Insufficiency by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Medical Equipment and Consumables
- 2.2.3 Drugs
- 2.3 Chronic Venous Insufficiency by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Chronic Venous Insufficiency Breakdown Data by Type
- 3.1 Global Chronic Venous Insufficiency Historic Market Size by Type (2021-2026)
- 3.2 Global Chronic Venous Insufficiency Forecasted Market Size by Type (2027-2032)
4 Chronic Venous Insufficiency Breakdown Data by Application
- 4.1 Global Chronic Venous Insufficiency Historic Market Size by Application (2021-2026)
- 4.2 Global Chronic Venous Insufficiency Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Chronic Venous Insufficiency Market Perspective (2021-2032)
- 5.2 Global Chronic Venous Insufficiency Growth Trends by Region
- 5.2.1 Global Chronic Venous Insufficiency Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Chronic Venous Insufficiency Historic Market Size by Region (2021-2026)
- 5.2.3 Chronic Venous Insufficiency Forecasted Market Size by Region (2027-2032)
- 5.3 Chronic Venous Insufficiency Market Dynamics
- 5.3.1 Chronic Venous Insufficiency Industry Trends
- 5.3.2 Chronic Venous Insufficiency Market Drivers
- 5.3.3 Chronic Venous Insufficiency Market Challenges
- 5.3.4 Chronic Venous Insufficiency Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Chronic Venous Insufficiency Players by Revenue
- 6.1.1 Global Top Chronic Venous Insufficiency Players by Revenue (2021-2026)
- 6.1.2 Global Chronic Venous Insufficiency Revenue Market Share by Players (2021-2026)
- 6.2 Global Chronic Venous Insufficiency Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Chronic Venous Insufficiency Head Office and Area Served
- 6.4 Global Chronic Venous Insufficiency Players, Product Type & Application
- 6.5 Global Chronic Venous Insufficiency Manufacturers Established Date
- 6.6 Global Chronic Venous Insufficiency Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Chronic Venous Insufficiency Market Size (2021-2032)
- 7.2 North America Chronic Venous Insufficiency Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Chronic Venous Insufficiency Market Size by Country (2021-2026)
- 7.4 North America Chronic Venous Insufficiency Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Chronic Venous Insufficiency Market Size (2021-2032)
- 8.2 Europe Chronic Venous Insufficiency Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Chronic Venous Insufficiency Market Size by Country (2021-2026)
- 8.4 Europe Chronic Venous Insufficiency Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Chronic Venous Insufficiency Market Size (2021-2032)
- 9.2 Asia-Pacific Chronic Venous Insufficiency Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Chronic Venous Insufficiency Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Chronic Venous Insufficiency Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Chronic Venous Insufficiency Market Size (2021-2032)
- 10.2 South America Chronic Venous Insufficiency Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Chronic Venous Insufficiency Market Size by Country (2021-2026)
- 10.4 South America Chronic Venous Insufficiency Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Chronic Venous Insufficiency Market Size (2021-2032)
- 11.2 Middle East & Africa Chronic Venous Insufficiency Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Suzhou Yinluo Medical Devices
- 12.1.1 Suzhou Yinluo Medical Devices Company Information
- 12.1.2 Suzhou Yinluo Medical Devices Business Overview
- 12.1.3 Suzhou Yinluo Medical Devices Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.1.4 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Product Portfolio
- 12.1.5 Suzhou Yinluo Medical Devices Recent Developments
- 12.2 Suzhou Tianhong Shengjie Medical Devices
- 12.2.1 Suzhou Tianhong Shengjie Medical Devices Company Information
- 12.2.2 Suzhou Tianhong Shengjie Medical Devices Business Overview
- 12.2.3 Suzhou Tianhong Shengjie Medical Devices Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.2.4 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Product Portfolio
- 12.2.5 Suzhou Tianhong Shengjie Medical Devices Recent Developments
- 12.3 Shanghai Lanmai Medical Technology
- 12.3.1 Shanghai Lanmai Medical Technology Company Information
- 12.3.2 Shanghai Lanmai Medical Technology Business Overview
- 12.3.3 Shanghai Lanmai Medical Technology Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.3.4 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Product Portfolio
- 12.3.5 Shanghai Lanmai Medical Technology Recent Developments
- 12.4 Shanghai Ensheng Medical Technology
- 12.4.1 Shanghai Ensheng Medical Technology Company Information
- 12.4.2 Shanghai Ensheng Medical Technology Business Overview
- 12.4.3 Shanghai Ensheng Medical Technology Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.4.4 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Product Portfolio
- 12.4.5 Shanghai Ensheng Medical Technology Recent Developments
- 12.5 Hangzhou Weiqiang Medical Technology
- 12.5.1 Hangzhou Weiqiang Medical Technology Company Information
- 12.5.2 Hangzhou Weiqiang Medical Technology Business Overview
- 12.5.3 Hangzhou Weiqiang Medical Technology Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.5.4 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Product Portfolio
- 12.5.5 Hangzhou Weiqiang Medical Technology Recent Developments
- 12.6 Zylox-Tonbridge Medical Technology
- 12.6.1 Zylox-Tonbridge Medical Technology Company Information
- 12.6.2 Zylox-Tonbridge Medical Technology Business Overview
- 12.6.3 Zylox-Tonbridge Medical Technology Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.6.4 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Product Portfolio
- 12.6.5 Zylox-Tonbridge Medical Technology Recent Developments
- 12.7 Teva
- 12.7.1 Teva Company Information
- 12.7.2 Teva Business Overview
- 12.7.3 Teva Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.7.4 Teva Chronic Venous Insufficiency Product Portfolio
- 12.7.5 Teva Recent Developments
- 12.8 Sun Pharma
- 12.8.1 Sun Pharma Company Information
- 12.8.2 Sun Pharma Business Overview
- 12.8.3 Sun Pharma Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.8.4 Sun Pharma Chronic Venous Insufficiency Product Portfolio
- 12.8.5 Sun Pharma Recent Developments
- 12.9 Philips
- 12.9.1 Philips Company Information
- 12.9.2 Philips Business Overview
- 12.9.3 Philips Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.9.4 Philips Chronic Venous Insufficiency Product Portfolio
- 12.9.5 Philips Recent Developments
- 12.10 Pfizer
- 12.10.1 Pfizer Company Information
- 12.10.2 Pfizer Business Overview
- 12.10.3 Pfizer Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.10.4 Pfizer Chronic Venous Insufficiency Product Portfolio
- 12.10.5 Pfizer Recent Developments
- 12.11 optimed Medizinische Instrumente
- 12.11.1 optimed Medizinische Instrumente Company Information
- 12.11.2 optimed Medizinische Instrumente Business Overview
- 12.11.3 optimed Medizinische Instrumente Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.11.4 optimed Medizinische Instrumente Chronic Venous Insufficiency Product Portfolio
- 12.11.5 optimed Medizinische Instrumente Recent Developments
- 12.12 Mylan
- 12.12.1 Mylan Company Information
- 12.12.2 Mylan Business Overview
- 12.12.3 Mylan Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.12.4 Mylan Chronic Venous Insufficiency Product Portfolio
- 12.12.5 Mylan Recent Developments
- 12.13 Medtronic
- 12.13.1 Medtronic Company Information
- 12.13.2 Medtronic Business Overview
- 12.13.3 Medtronic Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.13.4 Medtronic Chronic Venous Insufficiency Product Portfolio
- 12.13.5 Medtronic Recent Developments
- 12.14 Cook Ireland
- 12.14.1 Cook Ireland Company Information
- 12.14.2 Cook Ireland Business Overview
- 12.14.3 Cook Ireland Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.14.4 Cook Ireland Chronic Venous Insufficiency Product Portfolio
- 12.14.5 Cook Ireland Recent Developments
- 12.15 Boston Scientific
- 12.15.1 Boston Scientific Company Information
- 12.15.2 Boston Scientific Business Overview
- 12.15.3 Boston Scientific Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.15.4 Boston Scientific Chronic Venous Insufficiency Product Portfolio
- 12.15.5 Boston Scientific Recent Developments
- 12.16 BD(Angiomed)
- 12.16.1 BD(Angiomed) Company Information
- 12.16.2 BD(Angiomed) Business Overview
- 12.16.3 BD(Angiomed) Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.16.4 BD(Angiomed) Chronic Venous Insufficiency Product Portfolio
- 12.16.5 BD(Angiomed) Recent Developments
- 12.17 Allergan
- 12.17.1 Allergan Company Information
- 12.17.2 Allergan Business Overview
- 12.17.3 Allergan Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.17.4 Allergan Chronic Venous Insufficiency Product Portfolio
- 12.17.5 Allergan Recent Developments
- 12.18 AbbVie
- 12.18.1 AbbVie Company Information
- 12.18.2 AbbVie Business Overview
- 12.18.3 AbbVie Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.18.4 AbbVie Chronic Venous Insufficiency Product Portfolio
- 12.18.5 AbbVie Recent Developments
- 12.19 Abbott
- 12.19.1 Abbott Company Information
- 12.19.2 Abbott Business Overview
- 12.19.3 Abbott Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.19.4 Abbott Chronic Venous Insufficiency Product Portfolio
- 12.19.5 Abbott Recent Developments
- 12.20 3M
- 12.20.1 3M Company Information
- 12.20.2 3M Business Overview
- 12.20.3 3M Revenue in Chronic Venous Insufficiency Business (2021-2026)
- 12.20.4 3M Chronic Venous Insufficiency Product Portfolio
- 12.20.5 3M Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst